IMPACT BIOMEDICAL INC.
IBO · XNYSCIK 1834105fmd_0ZP5JY7KVJQCNZDF4PS8N593SMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2026, 18 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total revenues | 0 | – | – | 0 |
| Cost of revenue | – | – | – | 0 |
| Gross profit | – | – | – | (0) |
| Research and development | 1 | 2 | 0 | 0 |
| Selling, general and administrative | 0 | 0 | 1 | 1 |
| Total operating expenses | – | 4 | 29 | – |
| Operating income | (3) | (4) | (29) | (4) |
| Interest expense | 0 | 0 | 1 | 1 |
| Interest and investment income | 0 | 0 | – | – |
| Income before taxes | (8) | (4) | (25) | (14) |
| Income tax expense | (1) | – | 0 | (3) |
| Net income from continuing operations | (7) | – | (25) | (12) |
| Net income | (7) | (4) | (25) | (12) |
| Net income to common shareholders | (7) | (4) | – | – |